The Eeva™ Test from Auxogyn
The Eeva™ Test is used adjunctively to traditional morphology and provides IVF clinicians and patients with objective information about embryo development potential to aid in embryo selection. The Eeva Test is for use in women with multiple embryos suitable for transfer. The Eeva Test utilizes proprietary software that automatically analyzes embryo development against scientifically and clinically cell-division timing parameters. The Eeva Test provides quantitative data for each embryo’s development potential, so that IVF clinicians can optimize the treatment plan for their patients undergoing IVF procedures. The FDA recently allowed marketing of the Eeva System in the U.S. through its de novo classification process, a regulatory pathway for some novel, low- to moderate-risk medical devices that are first-of-a-kind. The Eeva System is also CE Marked and available for use in the EU, and is licensed for use in Canada by Health Canada.
For additional information regarding the Eeva Test, please visit www.eevaivf.com.
For risks and benefits click here.